Similar articles

Abstract: auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (AIFM1) variants in ANSD families and in some other sporadic cases. Here, to elucidate the pathogenic mechanisms underlying each AIFM1 variant, we generated AIF-null cells using the clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system and constructed AIF-wild type (WT) and AIF-mutant (mut) (p.‍T260A, p.‍R422W, and p.‍R451Q) stable transfection cell lines. We then analyzed AIF structure, coenzyme-binding affinity, apoptosis, and other aspects. Results revealed that these variants resulted in impaired dimerization, compromising AIF function. The reduction reaction of AIF variants had proceeded slower than that of AIF-WT. The average levels of AIF dimerization in AIF variant cells were only 34.5%‍‒‍49.7% of that of AIF-WT cells, resulting in caspase-independent apoptosis. The average percentage of apoptotic cells in the variants was 12.3%‍‒‍17.9%, which was significantly higher than that (6.9%‍‒‍7.4%) in controls. However, nicotinamide adenine dinucleotide (NADH) treatment promoted the reduction of apoptosis by rescuing AIF dimerization in AIF variant cells. Our findings show that the impairment of AIF dimerization by AIFM1 variants causes apoptosis contributing to ANSD, and introduce NADH as a potential drug for ANSD treatment. Our results help elucidate the mechanisms of ANSD and may lead to the provision of novel therapies.

听神经病相关AIFM1基因突变引起凋亡诱导因子二聚体形成障碍并导致细胞凋亡增加

[1]Al-WardyNM, Al-KindiMN, Al-KhabouriMJ, et al., 2016. A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy. Saudi Med J, 37(10):1068-1075.

[2]ArdissoneA, PiscosquitoG, LegatiA, et al., 2015. A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders. Neurology, 84(21):‍2193-2195.

[3]BanoD, PrehnJHM, 2018. Apoptosis-inducing factor (AIF) in physiology and disease: the tale of a repented natural born killer. eBioMedicine, 30:29-37.

[4]BergerI, Ben-NeriahZ, Dor-WolmanT, et al., 2011. Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing. Mol Genet Metab, 104(4):517-520.

[5]BirkmayerJGD, VreckoC, VolcD, et al., 1993. Nicotinamide adenine dinucleotide (NADH)‍—a new therapeutic approach to Parkinson’s disease. Comparison of oral and parenteral application. Acta Neurol Scand, 87(S146):‍32-35.

[6]BroseyCA, HoC, LongWZ, et al., 2016. Defining NADH-driven allostery regulating apoptosis-inducing factor. Structure, 24(12):2067-2079.

[7]Castro-MarreroJ, Sáez-FrancàsN, SegundoMJ, et al., 2016. Effect of coenzyme Q₁₀ plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome—a randomized, controlled, double-blind trial. Clin Nutr, 35(4):‍826-834.

[8]ChengX, LiL, BrashearsS, et al., 2005. Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf. Am J Med Genet, 139A(1):13-18.

[9]CheungECC, JozaN, SteenaartNAE, et al., 2006. Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J, 25(17):4061-4073.

[10]ChiuYH, WuCC, LuYC, et al., 2010. Mutations in the OTOF gene in Taiwanese patients with auditory neuropathy. Audiol Neurootol, 15(6):364-374.

[11]DelmaghaniS, del CastilloFJ, MichelV, et al., 2006. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. Nat Genet, 38(7):770-778.

[12]DemarinV, PodobnikSS, Storga-TomicD, et al., 2004. Treatment of Alzheimer’s disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study. Drugs Exp Clin Res, 30(1):27-33.

[13]DiodatoD, TascaG, VerrigniD, et al., 2016. A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease. Eur J Hum Genet, 24(3):463-466.

[14]FerreiraP, VillanuevaR, Martínez-JúlvezM, et al., 2014. Structural insights into the coenzyme mediated monomer-dimer transition of the pro-apoptotic apoptosis inducing factor. Biochemistry, 53(25):4204-4215.

[15]GhezziD, SevrioukovaI, InvernizziF, et al., 2010. Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet, 86(4):639-649.

[16]HangenE, BlomgrenK, BénitP, et al., 2010. Life with or without AIF. Trends Biochem Sci, 35(5):278-287.

[17]HangenE, FéraudO, LachkarS, et al., 2015. Interaction between AIF and CHCHD4 regulates respiratory chain biogenesis. Mol Cell, 58(6):1001-1014.

[18]HeimerG, EyalE, ZhuX, et al., 2018. Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin. Eur J Paediatr Neurol, 22(1):93-101.

[19]HerrmannJM, RiemerJ, 2020. Apoptosis inducing factor and mitochondrial NADH dehydrogenases: redox-controlled gear boxes to switch between mitochondrial biogenesis and cell death. Biol Chem, 402(3):289-297.

[20]HuB, WangM, CastoroR, et al., 2017. A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes. Eur J Neurol, 24(12):1499-1506.

[21]Lang-RothR, Fischer-KrallE, KornblumC, et al., 2017. AUNA2: a novel type of non-syndromic slowly progressive auditory synaptopathy/auditory neuropathy with autosomal-dominant inheritance. Audiol Neurootol, 22(1):30-40.

[22]LiC, BrantE, BudakH, et al., 2021. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(4):253-284.

[23]MatsuokaAJ, MorrisseyZD, ZhangCY, et al., 2017. Directed differentiation of human embryonic stem cells toward placode-derived spiral ganglion-like sensory neurons. Stem Cells Transl Med, 6(3):923-936.

[24]MierzewskaH, RydzaniczM, BiegańskiT, et al., 2017. Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation—a novel phenotype of the mitochondrial disease. Clin Genet, 91(1):30-37.

[25]PenidoRC, IsaacML, 2013. Prevalence of auditory neuropathy spectrum disorder in an auditory health care service. Braz J Otorhinolaryngol, 79(4):429-433.

[26]PittelliM, FeliciR, PitozziV, et al., 2011. Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol Pharmacol, 80(6):1136-1146.

[27]ReinhardtC, ArenaG, NedaraK, et al., 2020. AIF meets the CHCHD4/Mia40-dependent mitochondrial import pathway. Biochim Biophys Acta Mol Basis Dis, 1866(6):165746.

[28]RinaldiC, GrunseichC, SevrioukovaIF, et al., 2012. Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. Am J Hum Genet, 91(6):1095-1102.

[29]RomanosJ, KimuraL, FáveroML, et al., 2009. Novel OTOF mutations in Brazilian patients with auditory neuropathy. J Hum Genet, 54(7):382-385.

[30]Romero-TamayoS, LaplazaR, Velazquez-CampoyA, et al., 2021. W196 and the β‍-hairpin motif modulate the redox switch of conformation and the biomolecular interaction network of the apoptosis-inducing factor. Oxid Med Cell Longev, 2021:6673661.

[31]Sánchez-MartínezA, Benito-OrejasJI, Tellería-OrriolsJJ, et al., 2017. Autosomal dominant auditory neuropathy and variant DIAPH3 (c.-173C>T). Acta Otorrinolaringol Esp, 68(3):183-185.

[32]SanchoP, Sánchez-MonteagudoA, ColladoA, et al., 2017. A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation. Neurogenetics, 18(4):245-250.

[33]SantarelliR, CamaE, ScimemiP, et al., 2008. Audiological and electrocochleography findings in hearing-impaired children with connexin 26 mutations and otoacoustic emissions. Eur Arch Otorhinolaryngol, 265(1):43-51.

[34]SchoenCJ, EmerySB, ThorneMC, et al., 2010. Increased activity of Diaphanous homolog 3 (DIAPH3)/diaphanous causes hearing defects in humans with auditory neuropathy and in Drosophila. Proc Natl Acad Sci USA, 107(30):13396-13401.

[35]SevrioukovaIF, 2011. Apoptosis-inducing factor: structure, function, and redox regulation. Antioxid Redox Signal, 14(12):2545-2579.

[36]SevrioukovaIF, 2016. Structure/function relations in AIFM1 variants associated with neurodegenerative disorders. J Mol Biol, 428(18):3650-3665.

[37]StarrA, SiningerYS, PrattH, 2000. The varieties of auditory neuropathy. J Basic Clin Physiol Pharmacol, 11(3):‍215-230.

[38]StarrA, IsaacsonB, MichalewskiHJ, et al., 2004. A dominantly inherited progressive deafness affecting distal auditory nerve and hair cells. J Assoc Res Otolaryngol, 5(4):411-426.

[39]SusinSA, LorenzoHK, ZamzamiN, et al., 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397(6718):441-446.

[40]TangDL, KangR, BergheTV, et al., 2019. The molecular machinery of regulated cell death. Cell Res, 29(5):347-364.

[41]TekinM, AkcayozD, IncesuluA, 2005. A novel missense mutation in a C2 domain of OTOF results in autosomal recessive auditory neuropathy. Am J Med Genet, 138A(1):6-10.

[42]TranebjærgL, StrenzkeN, LindholmS, et al., 2018. The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management. Hum Genet, 137(2):111-127.

[43]VargaR, KelleyPM, KeatsBJ, et al., 2003. Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene. J Med Genet, 40(1):‍45-50.

[44]WangQJ, LiRH, ZhaoH, et al., 2005. Clinical and molecular characterization of a Chinese patient with auditory neuropathy associated with mitochondrial 12S rRNA T1095C mutation. Am J Med Genet, 133A(1):27-30.

[45]WangQJ, LiQZ, RaoSQ, et al., 2006. AUNX1, a novel locus responsible for X linked recessive auditory and peripheral neuropathy, maps to Xq23‍‍‒‍‍27.3. J Med Genet, 43(7):e33.

[46]YangW, LiSS, ZhangX, et al., 2015. Gene editing and cell therapy based on induced pluripotent stem cells. Chin J Cell Biol, 37(1):90-99.

[47]YingWH, 2008. NAD⁺/NADH and NADP⁺/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal, 10(2):179-206.

[48]YuSW, WangHM, PoitrasMF, et al., 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 297(5579):259-263.

[49]YuSW, AndrabiSA, WangHM, et al., 2006. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci USA, 103(48):18314-18319.

[50]ZhuKQ, SwansonRA, YingWH, 2005. NADH can enter into astrocytes and block poly(ADP-ribose) polymerase-‍1-mediated astrocyte death. NeuroReport, 16(11):‍1209-1212.

[51]ZongL, GuanJ, EalyM, et al., 2015. Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder. J Med Genet, 52(8):523-531.